NJBEST
ESPR icon

New Jersey Better Educational Savings Trust’s Esperion Therapeutics ESPR Stock Holding History

New Jersey Better Educational Savings Trust’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,000
Closed -$203K – 191
2016
Q1 		$203K Buy
12,000
+1,000
+9% +$16.1K 0.14% 177
2015
Q4 		$245K Buy
11,000
+1,000
+10% +$25.2K 0.17% 168
2015
Q3 		$236K Buy
+10,000
New +$628K 0.17% 161

Other funds holding ESPR

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Discovery Capital Management
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

New Jersey Better Educational Savings Trust's ESPR Position: Q2 2016 in Review

New Jersey Better Educational Savings Trust sold out of Esperion Therapeutics (ESPR) in Q2 2016, closing a stake of 12,000 shares — an estimated $203K sold.

New Jersey Better Educational Savings Trust first reported a position in ESPR in Q3 2015 and held it in 3 quarters. The position peaked at $245K in Q4 2015. 102 funds tracked by Wall St. Rank hold ESPR as of Q2 2016.

  • New Jersey Better Educational Savings Trust reported no remaining Esperion Therapeutics position as of Q2 2016 after selling out during the quarter.
  • New Jersey Better Educational Savings Trust sold 12,000 Esperion Therapeutics shares in Q2 2016, an estimated $203K.
  • New Jersey Better Educational Savings Trust first reported a position in Esperion Therapeutics in Q3 2015 and held it in 3 quarters.
  • New Jersey Better Educational Savings Trust's Esperion Therapeutics position peaked at $245K in Q4 2015.
  • 102 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2016.

Based on New Jersey Better Educational Savings Trust's 13F filing for Q2 2016, filed 2 Aug 2016.